Patents by Inventor Enrique Maria Ocio

Enrique Maria Ocio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101
    Publication number: 20230285363
    Abstract: The present invention is directed to a combination comprising a glucocorticoid and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Application
    Filed: December 19, 2022
    Publication date: September 14, 2023
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio
  • PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
    Publication number: 20230241033
    Abstract: The present invention is directed to a combination comprising a proteasome inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Application
    Filed: December 22, 2022
    Publication date: August 3, 2023
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio
  • Pharmaceutical combinations for treating cancer
    Patent number: 11559516
    Abstract: The present invention is directed to a combination comprising a proteasome inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: January 24, 2023
    Assignee: Purdue Pharmaceutical Products L.P.
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio
  • Combination comprising a glucocorticoid and EDO-S101
    Patent number: 11541038
    Abstract: The present invention is directed to a combination comprising a glucocorticoid and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: January 3, 2023
    Assignee: Purdue Pharmaceutical Products L.P.
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio
  • PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
    Publication number: 20210346351
    Abstract: The present invention is directed to a combination comprising a proteasome inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Application
    Filed: March 25, 2021
    Publication date: November 11, 2021
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio
  • COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101
    Publication number: 20210059989
    Abstract: The present invention is directed to a combination comprising a glucocorticoid and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Application
    Filed: August 14, 2020
    Publication date: March 4, 2021
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio
  • NEW TREATMENTS OF MULTIPLE MYELOMA
    Publication number: 20200261534
    Abstract: The present invention relates to the field of oncology. More specifically, it relates to the use of peptidomimetic compounds in the treatment of multiple myeloma, especially in refractory or relapsing multiple myeloma and/or in combination with other antitumoral agents.
    Type: Application
    Filed: September 10, 2018
    Publication date: August 20, 2020
    Inventors: Santiago ESTEBAN MARTÍN, Laura NEVOLA, Enrique María OCIO SAN MIGUEL, Patryk KRZEMINSKI, Mercedes GARAYOA
  • Combination comprising a glucocorticoid and EDO-S101
    Patent number: 10744120
    Abstract: The present invention is directed to a combination comprising a glucocorticoid and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Grant
    Filed: May 26, 2015
    Date of Patent: August 18, 2020
    Assignee: PURDUE PHARMACEUTICAL PRODUCTS L.P.
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio
  • PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
    Publication number: 20190343807
    Abstract: The present invention is directed to a combination comprising a proteasome inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Application
    Filed: July 22, 2019
    Publication date: November 14, 2019
    Inventors: Thomas Mehrling, Enrique Maria Ocio
  • Pharmaceutical combinations for treating cancer
    Patent number: 10406138
    Abstract: The present invention is directed to a combination comprising a proteasome inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: September 10, 2019
    Assignee: Purdue Pharmaceutical Products L.P.
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio
  • PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
    Publication number: 20180369204
    Abstract: The present invention is directed to a combination comprising a proteasome inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Application
    Filed: May 21, 2018
    Publication date: December 27, 2018
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio
  • COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101
    Publication number: 20170296513
    Abstract: The present invention is directed to a combination comprising a glucocorticoid and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Application
    Filed: May 26, 2015
    Publication date: October 19, 2017
    Applicant: Purdue Pharmaceutical Products L.P.
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio
  • PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
    Publication number: 20170151218
    Abstract: The present invention is directed to a combination comprising a proteasome inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.
    Type: Application
    Filed: May 26, 2015
    Publication date: June 1, 2017
    Applicant: Purdue Pharmaceutical Products L.P.
    Inventors: Thomas Jorg Mehrling, Enrique Maria Ocio